Evidence shows PPI risks are overblown
Recent studies linking proton pump inhibitors (PPIs) to an increased risk of stroke have been refuted in a paper that suggests previous results may be due to residual confounding.
PPIs have been linked to a host of chronic conditions, including premature death, a heightened risk of chronic kidney disease, dementia and bone fracture in people with osteoporosis.
But the latest study illustrates the pitfalls of using observational database studies to identify potential adverse effects.
In this analysis, which used data from two large prospective cohort studies